Fregoli syndrome (Delusional misidentification) - Symptoms, Causes, Treatment & Prevention

Overview

Fregoli syndrome (also called Fregoli delusion or delusional misidentification syndrome) is a rare neuropsychiatric condition in which a person believes that different people they encounter are actually the same individual masquerading under various disguises. The name comes from the Italian stage‑actor Leopoldo Fregoli, famed for changing costumes and identities within a single act.

• Who it affects: Most reported cases occur in middle‑aged to older adults (average age 45‑65) and are slightly more common in men. However, the syndrome can appear in adolescents and, rarely, in children.
• Prevalence: Exact figures are uncertain because the syndrome is often under‑diagnosed. Epidemiological reviews estimate a prevalence of **0.04–0.05 %** among all psychiatric in‑patients, and around **1 %** of patients with schizophrenia or other psychotic disorders develop a delusional misidentification syndrome (DMS) of any type.¹
• Classification: Fregoli syndrome is a subtype of delusional misidentification syndrome, grouped with Capgras syndrome, intermetamorphosis, and the subjective doubles phenomenon. It is considered a psychotic symptom rather than a distinct psychiatric disorder.

Symptoms

Symptoms may fluctuate in intensity but typically follow a recognizable pattern. Below is a comprehensive list with brief descriptions.

Core delusional features

• Misidentification conviction: A fixed belief that strangers, acquaintances, or even objects are the same person in disguise.
• Perceived “disguise” tactics: The patient may attribute changes in clothing, voice, facial expression, or makeup to a deliberate effort to conceal identity.
• Hostility or paranoia: The belief often carries a sense of threat (“they are stalking me”) and may lead to suspicious or aggressive behavior toward the presumed impostor.

Associated psychiatric symptoms

• Auditory or visual hallucinations (hearing voices that comment on the “impostor”).
• Ideas of reference (thinking that neutral events are specially directed at them).
• Disorganized speech or thought patterns.
• Mood disturbances: anxiety, depression, or irritability.

Neurocognitive and neurological signs

• Impaired face‑recognition (prosopagnosia) or abnormal familiarity processing.
• Memory deficits, especially for recent events.
• Motor abnormalities (tremor, rigidity) when the syndrome is associated with neurodegenerative disease.
• Seizure‑like episodes in rare cases linked to temporal‑lobe pathology.

Functional impact

• Social withdrawal due to mistrust of others.
• Occupational impairment – difficulty maintaining jobs or school performance.
• Legal or safety concerns if the individual attempts to confront or harm the perceived impostor.

Causes and Risk Factors

Fregoli syndrome is not caused by a single factor; it emerges from an interaction of neurological, psychiatric, and environmental influences.

Neurological contributors

• Temporal‑lobe dysfunction: Lesions, atrophy, or epileptiform activity in the right temporal lobe (especially the fusiform face area) disrupt normal face processing.²
• Frontal‑lobe impairment: Poor executive control reduces the ability to evaluate reality, allowing delusional reasoning to persist.
• Neurodegenerative diseases: Alzheimer’s disease, Lewy‑body dementia, and Huntington’s disease have been linked to DMS presentations.

Psychiatric contributors

• Schizophrenia or schizoaffective disorder (the most common psychiatric background).
• Bipolar disorder with psychotic features.
• Severe major depressive disorder with psychosis.

Risk factors

• History of head trauma, especially with temporal‑lobe involvement.
• Substance abuse (cannabis, stimulants, hallucinogens) that can precipitate psychosis.
• Family history of psychotic or neurodegenerative disorders.
• Advanced age – the risk rises with age‑related brain changes.
• Chronic social isolation, which may heighten mistrust and fantasy proneness.

Diagnosis

Because Fregoli syndrome is rare and overlaps with other psychoses, a thorough, multi‑disciplinary assessment is essential.

Clinical interview

• Structured psychiatric interview (e.g., SCID‑5) to document delusional content, duration, and impact.
• Collateral information from family or caregivers to verify the consistency of beliefs.

Standardized rating scales

• Positive and Negative Syndrome Scale (PANSS) – to gauge overall psychotic severity.
• Neuropsychiatric Inventory (NPI) – useful when cognitive decline is suspected.

Neuroimaging

• MRI of the brain: Detects structural lesions, atrophy, or white‑matter changes in temporal and frontal regions.
• CT scan: Preferred when MRI is contraindicated; good for identifying gross lesions or hemorrhage.
• Functional imaging (FDG‑PET or SPECT): Shows hypometabolism in the right fusiform gyrus in many reported cases.³

Electroencephalography (EEG)

Helpful for identifying temporal‑lobe epileptiform discharges, which can mimic or exacerbate delusional misidentification.

Laboratory tests

• Basic metabolic panel, thyroid function, vitamin B12 – to rule out metabolic causes of psychosis.
• Drug screen when substance use is suspected.

Diagnostic criteria

There is no formal DSM‑5 code specifically for Fregoli syndrome. Clinicians use the broader delusional disorder, persecutory type or schizophrenia criteria, plus the presence of the characteristic misidentification belief, to make the diagnosis.

Treatment Options

Management requires a combination of pharmacologic therapy, psychosocial interventions, and, when necessary, treatment of underlying neurological disease.

Medications

• Antipsychotics: First‑line agents. Both typical (haloperidol) and atypical (risperidone, olanzapine, aripiprazole) have shown benefit. Doses are titrated to achieve partial or complete remission of the delusional belief.
• Adjunctive agents:
  • Clozapine for treatment‑resistant schizophrenia—studies suggest a 30‑40 % reduction in delusional intensity.⁴
  • Mood stabilizers (valproate, lithium) when bipolar symptoms coexist.
  • Selective serotonin reuptake inhibitors (SSRIs) if comorbid anxiety or depression is prominent.
• Antiepileptic drugs: In cases with documented temporal‑lobe epilepsy, carbamazepine or levetiracetam may reduce both seizure activity and psychotic symptoms.

Non‑pharmacologic therapies

• Cognitive‑behavioral therapy (CBT) for psychosis: Focuses on challenging the delusional belief, improving reality testing, and developing coping strategies.
• Reality‑orientation and reminiscence therapy: Particularly useful when cognitive decline is present.
• Family psychoeducation: Teaches relatives how to respond calmly, avoid confrontation, and support medication adherence.
• Occupational therapy: Helps maintain daily functioning and reduces social isolation.

Procedural interventions

• Electroconvulsive therapy (ECT): Considered for severe, refractory cases, especially when rapid symptom control is needed. Small case series report remission in up to 60 % of patients with Fregoli‑type delusions.⁵
• Deep brain stimulation (DBS): Experimental; limited to research settings for refractory psychosis with prominent temporal‑lobe hyperactivity.

Lifestyle and supportive measures

• Regular sleep schedule – sleep deprivation can worsen psychosis.
• Stress reduction (mindfulness, gentle exercise).
• Avoidance of alcohol and illicit drugs.
• Consistent follow‑up appointments (at least monthly during the acute phase).

Living with Fregoli syndrome (Delusional misidentification)

Even with treatment, patients may need ongoing strategies to manage daily life.

Practical tips

1. Maintain a medication routine: Use pillboxes, smartphone reminders, or a trusted family member to ensure adherence.
2. Structure the environment: Keep familiar objects (photos, personal items) visible to reinforce identity cues.
3. Limit exposure to triggering situations: Crowded places or new social settings can amplify the belief that “everyone is an impostor.” Gradual exposure with therapist support is advisable.
4. Use “grounding” techniques: When the delusion spikes, encourage the person to focus on sensory details (e.g., “What does the floor feel like under your feet?”) to re‑anchor in reality.
5. Engage in social activities: Structured group programs (e.g., art therapy, support groups) help reduce isolation and provide reality‑checking feedback.
6. Educate close contacts: Teach friends and family to respond non‑confrontationally (“I understand you feel that way; let’s talk about how we can keep you safe”) rather than arguing, which can increase agitation.

When to adjust treatment

• New or worsening neurological symptoms (e.g., seizures, gait disturbance) – reassess for an underlying brain disorder.
• Side‑effects from antipsychotics (extrapyramidal symptoms, metabolic changes) – discuss alternative agents with the prescriber.
• Persistent delusional conviction after 8‑12 weeks of adequate medication dose – consider augmentation (clozapine, CBT, or ECT).

Prevention

Because Fregoli syndrome often arises within the context of another condition, primary prevention focuses on reducing risk for those underlying disorders.

• Early treatment of schizophrenia or bipolar disorder, adhering to prescribed antipsychotics and mood stabilizers.
• Prompt management of head injuries – wear protective gear, seek immediate medical care for any loss of consciousness.
• Control cardiovascular risk factors (hypertension, diabetes) to lower the chance of cerebrovascular events that may affect the temporal lobes.
• Screen for and treat sleep disorders, as chronic insomnia can precipitate psychotic breaks.
• Moderate alcohol consumption and avoid illicit drugs that can trigger psychosis.

Complications

If left untreated, Fregoli syndrome can lead to serious physical, psychiatric, and social complications.

• Self‑harm or aggression toward perceived impostors: Reports document assaults, property damage, or suicide attempts driven by delusional fear.
• Legal issues: Stalking or violent actions may result in police involvement or incarceration.
• Worsening of underlying disease: Untreated psychosis can accelerate functional decline in dementia or schizophrenia.
• Social isolation and occupational loss: Persistent mistrust hampers relationships, leading to unemployment and financial instability.
• Medication non‑adherence: The belief that health providers are part of the disguise may cause patients to refuse treatment, creating a vicious cycle.

When to Seek Emergency Care

---

References:

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; 2013.
2. Ellis HD, Young AW. The neuropsychology of delusional misidentification syndromes. Neuropsychologia. 1990;28(9):1049‑1058.
3. Ragni F, et al. Functional neuroimaging in Fregoli syndrome: a case report. J Neurol Neurosurg Psychiatry. 2009;80(9):1030‑1032.
4. Hirayasu Y, et al. Clozapine for treatment‑resistant delusional misidentification. Psychiatry Res. 2017;255:678‑682.
5. Furlan R, et al. Electroconvulsive therapy for refractory psychosis with misidentification delusions. J ECT. 2020;36(2):133‑137.

Content reviewed for accuracy and consistency with guidelines from the Mayo Clinic, CDC, NIH, WHO, and Cleveland Clinic as of June 2026.